Cooley Advises Underwriters on Onconova Therapeutics IPO

San Francisco, Calif. – August 8, 2013 – Cooley LLP announced today that it advised the underwriters on Onconova Therapeutics, Inc.'s initial public offering. Onconova is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Onconova now trades on the NASDAQ Global Stock Market under the symbol "ONTX."

Citigroup Global Markets Inc. and Leerink Swann LLC acted as joint book-running managers for the offering; Piper Jaffray & Co. and Janney Montgomery Scott LLC acted as co-managers.

The Cooley corporate securities team advising the underwriters was led by partner Drew Williamson and included partner Brent Siler, special counsel Brian Leaf and associate Robert E. Jones. Critical support for the offering was provided by partner Bill Christiansen (intellectual property); partners Natasha Leskovsek and Andrew Gantt and associate David Sclar (regulatory); partner Ken Krisko and associate Jennifer Raab (life sciences) and partner Susan Cooper Philpot (tax).

According to American Lawyer's 2012 Corporate Scorecard, Cooley served as issuer counsel on 40 US equity offerings, ranking as the most active law firm advising issuers in the country. Cooley was also ranked as the third most active law firm advising underwriters on US IPOs.

About Cooley LLP
 
Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small clients with big ideas to international clients with diverse legal needs, Cooley has the breadth of legal resources to enable clients of all shapes and sizes to seize opportunities in today's global marketplace. We represent clients across a broad array of dynamic industry sectors, including the financial sector, law firms, media, technology, life sciences, health care, venture capital, clean energy, real estate and retail.

Cooley has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC and Shanghai, China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.